Society for Neuroscience - Search

Skip Navigation

  • join logo Join
  • hands shaped like a yellow heart icon Give
  • advocate logo Advocate
  • publish logo Publish
  • Icon with thought bubbles Learn
Shop Sign In
SfN Logo 2025
  • Membership
    • Learn About Membership
      • Individual Member Benefits
      • Institutional Program Member Benefits
      • Sustaining Associate Member Benefits
      • Get Involved at SfN
    • Become a Member
      • Sponsorship Information for New Members
      • Membership Categories & Fees
      • Membership Fees for Developing Countries
      • Renew Individual Membership
    • Member Resources
      • Automatic Renewals
      • Frequently Asked Questions
      • Individual Member Directory
      • Member Obituaries and Memorial Donations
    • Learn About Local Chapters
      • Start or Reactivate a Chapter
      • Resources for Chapters
      • Submit Annual Report
      • Chapter Directory
      • Frequently Asked Questions
  • Meetings
    • Meetings Overview
    • Neuroscience 2025
      • Presenter Resources
      • Itinerary Planner and Mobile App
      • Sessions and Events
      • Registration
      • Housing and Travel
      • Exhibits
      • Advertising and Sponsorship
      • FAQs
    • Global Events
      • SfN Virtual Events
    • Past and Future Annual Meetings
      • Neuroscience 2024
      • Neuroscience 2023
      • Search Past Annual Meeting Abstracts
      • Attendance Statistics
    • Meeting Policies and Guidelines
      • Code of Conduct at SfN Events
      • Growth and Opportunity Strategy
      • Photography & Recording Policy
      • Presenter Guidelines and Policies for SfN Events
    • Meeting Awards
      • Trainee Professional Development Award
      • International Travel Awards
      • FENS Member Awards to SfN Annual Meeting
      • IBRO Member Awards to SfN Annual Meeting
      • JNS Member Awards to SfN Annual Meeting
  • Careers
    • Careers Overview
    • Institutional Program (IP) Directory
    • NeuroJobs Career Center
      • Job Seekers
      • Employers
    • 2025 Graduate School Fair
    • Career Tools and Resources
      • Neuronline
      • Neurobiology of Disease Workshop
      • Responsible Conduct of Research Short Courses
      • Neuroscience Departments and Program Workshop
      • Global Funding Sources
    • Higher Education and Training
      • Core Competencies
      • Neuroscience Training Program Survey
    • Awards
      • Outstanding Career and Research Achievements
      • Early Career
  • Initiatives
    • Initiatives Overview
    • Awards
      • 2025 Award Recipients
      • Awards and Prizes FAQ
      • Trainee Professional Development Award
    • Neuroscience Scholars Program
    • Neuronline
      • Webinars
      • Articles
      • Videos
      • Podcasts
      • Collections
    • Resources to Stay Connected
      • SfN Zoom Backgrounds
    • Community
    • Women and Neuroscience
      • Increasing Women in Neuroscience (IWiN) Courses & Toolkit
      • Celebration of Women in Neuroscience Event
      • Awards
    • Animals in Research
      • Support for Members and Institutions
      • Tools and Resources
      • Resources for Medical Students
    • Public Education Programs
      • Resources for Educators
      • Brain Awareness Video Contest
      • Life of a Neuron Exhibit
  • Advocacy
    • Advocacy Overview
    • Advocacy Response
    • Advocacy Network
      • The NeuroAdvocate Challenge
      • Advocacy Action Center
      • Advocacy Best Practices
      • Advocacy Network News
      • Advocacy Training Seminars
    • US Advocacy Programs
      • Capitol Hill Day
      • Connect with Policymakers
      • Early Career Policy Ambassadors
      • Partner with a Local Chapter
      • Engage the Media
    • Global Advocacy Programs
      • Global Neuroscience Initiatives
      • Global Funding
      • North American Programs
    • Science Funding
      • Advocacy Videos
      • Advocacy Resources
      • US Neuroscience Initiatives
      • Funding Priorities and Processes
    • Policy Positions
      • Statements and Testimony
      • Sign-On Letters
  • Outreach
    • Outreach Overview
    • BrainFacts.org
    • Find a Neuroscientist
    • Brain Awareness Campaign
      • Webinar: The ABC's of BAW
      • How to Get Involved
    • Awards
      • Award for Education in Neuroscience
      • Next Generation Award
      • Chapter of the Year Award
      • Science Educator Award
  • Publications
    • Publications Overview
    • SfN News
    • JNeurosci
    • eNeuro
    • SfN Nexus
    • Neuroscience Quarterly
    • Annual Report
    • History of Neuroscience Autobiographical Chapters
  • About
    • About Overview
    • Mission and Strategic Plan
    • What We Do
      • Annual Report
      • Bylaws
      • Resolutions to the Bylaws
      • Environmental Commitment
      • Strategic Partners
      • History of SfN
    • SfN 50th Anniversary Celebration
    • NIH Public Health Service-Supported Funding Financial Conflict of Interest Policy
    • Volunteer
      • SfN Council
      • SfN Presidents
      • Committees
      • Elections
      • Call for Nominations
    • Professional Conduct
      • SfN Ethics Policy
      • Guidelines for Responsible Conduct Regarding Scientific Communication
      • Code of Conduct at SfN Events
      • Commitment to Scientific Integrity
      • Neuronline Digital Learning Community Guidelines
    • History of Neuroscience
      • Autobiographical Chapters
      • Autobiographical Videos of Prominent Neuroscientists
      • Classic Papers
      • Neuroscience History Resources
      • Robert Doty's Chapter on Neuroscience
    • Careers and Staff
      • Staff List
  1. Search

Filter

  • (2)
  • (1)
  • (3)
  • (6)
  • (8)
  • (1)
  • (574)
  • (3)
  • (2)
  • (8)
Filter
221 - 230 of 892 results
  • Abstract
    A chronic low dose of delta-9-tetrahydrocannabinol restores cognitive function in old mice by histone acetylation
    Brain aging is accompanied by a number of cellular and molecular changes that may ultimately lead to cognitive deficits. One of these changes is a decline in the activity of the endocannabinoid system characterised by diminished 2-arachidonoylglycerol l...
    Nov 4, 2018
  • Abstract
    Adolescent ∆-9 tetrahydrocannabinol exposure induces different long-lasting changes in the dorsal and ventral portions of the hippocampal formation
    Sustained cannabis consumption during adolescence has been widely associated to cognitive impairments and enhanced risks for anxiety/mood disorders at adulthood. In particular, clinical and preclinical evidence has demonstrated that chronic exposure to ...
    Nov 11, 2021
  • Abstract
    Cannabinoid-based alzheimer therapy: Effects of tetrahydrocannabinol on anxiety, memory and neuron loss in Tg4-42 mice
    Introduction: Limited therapeutic effects of current Alzheimer (AD) treatments highlight the need for new research approaches. Drugs that simultaneously target different aspects of AD could provide therapeutic benefits. Targeting the endocannabinoid sys...
    Nov 14, 2017
  • Abstract
    Effects of intraperitoneal injections of thc on bold signal using functional magnetic resonance imaging in awake rats
    Cannabis is one of the most frequently used illicit drugs worldwide, and has been banned in the United States and Canada since the early 1900s. A recent United Nations report places cannabis at the top of the 2010 illicit drug use list, at an estimated ...
    Nov 15, 2016
  • Abstract
    Cannabidiol reduces the duration and severity of thermally evoked seizures in a mouse model of Dravet Syndrome
    Dravet Syndrome (DS) is one of the most severe childhood neuropsychiatric diseases, with intractable epilepsy, febrile seizures developmental delay, ataxia, sleep disorder, autistic-like behaviors, frequent premature death and profound cognitive deficit...
    Nov 14, 2016
  • Abstract
    Cannabidiol into basolateral amygdaloid complex does not modifiy anxiety-like behavior in the elevated plus maze
    Cannabidiol microinjected into basolateral amygdaloid complex does not modifiy anxiety-like behavior in the elevated plus maze. Lisboa, S.F.S.; Guimarães, F.S. Pharmacology Department, Faculty of Medicine of Ribeirão Preto, FMRP/USP, Ribeirão Preto - Sã...
    Nov 4, 2007
  • Abstract
    Cannabidiolic acid controls seizure-like activity and neuronal excitability
    Intoxicating tetrahydrocannabinol (THC) and non-intoxicating cannabidiol (CBD) are the two most prevalent phytocannabinoids found in cannabis sativa plants. CBD is well studied in multiple disease models, especially as anti-convulsant in treatment of in...
    Nov 14, 2016
  • Abstract
    Identification of cannabinoid CB1 receptors in midbrain dopamine neurons
    Δ9-tetrahydrocannabinol (THC) is the principal psychoactive constituent of marijuana or cannabis. The major effect of THC is mainly mediated by cannabinoid CB1 receptors (CB1Rs). THC produces both rewarding and aversive effects in experimental animals. ...
    Nov 12, 2016
  • Abstract
    Developmental exposure to cannabidiol via intraperitoneal injection or passive inhalation is without substantial behavioral consequences on locomotor behavior, anxiety, and spatial learning in mice
    Cannabidiol (CBD) is a non-intoxicating phytocannabinoid with rapidly escalating popularity for the treatment of numerous off-label conditions including pain, anxiety, depression, hyperactivity, and autism spectrum disorder. Since CBD consumption is gen...
    Nov 11, 2021
  • Abstract
    Δ9-THC MODULATES THE ACUTE EFFECTS AND THE LONG TERM NEUROTOXICITY OF MDMA (ECSTACY) IN RATS.
    MDMA (Ecstacy) is a drug that is widely used by young people in many countries. There is increasing evidence that heavy use of MDMA damages brain serotonin (5-HT) systems, leading to chronic emotional and cognitive problems. We have shown that male Wistar rats briefly exposed to MDMA (4 x 5 mg/kg i.p. over four hours on each of two days) show long term increases in anxiety-like behavior three months after MDMA exposure (Morley et al EJP (2001) 433, 91-99). Human MDMA users frequently consume cannabis while under the influence of MDMA and the present study examined whether this might modulate the long term behavioral and neurotoxic effects of MDMA in rats. The active constituent of cannabis Δ9-THC (4 x 2.5 mg/kg over 4 h) reversed the acute hyperthermic effects of MDMA (4 x 5 mg/kg) on each of two days of administration, with rats given the MDMA/THC combination showing a robust hypothermia. Six weeks later rats that had received the MDMA/THC combination were less anxious on the emergence test than rats that...
    Nov 6, 2002
  • Previous
  • 21
  • 22
  • 23
  • 24
  • 25
  • Next

Featured

  • SfN Selects Kevin B. Marvel, PhD, as Next Executive Director
  • Read the Neuroscience Quarterly - Fall 2025
  • Renew your SfN Membership Today!
SfN Websites
  • BrainFacts.org logo
  • eNeuro logo
  • JNeurosci logo
  • Neuronline logo
Engage with SfN
  • join Join
  • give Give
  • advocate Advocate
  • publish Publish
Quick Links
  • SfN News
  • For Press
  • Global Events
  • Contact Us
  • Advertise
  • Code of Conduct
  • Jobs at SfN
  • SfN Store
  • Social Media
Follow SfN
  • BlueSky logo
  • Facebook logo
  • Instagram logo
  • LinkedIn logo

  • Threads logo
  • X Logo
  • YouTube logo
SfN logo with "SfN" in a blue box next to Society for Neuroscience in red text and the SfN tag line that reads "Advancing the understanding of the brain and nervous system"
1121 14th Street NW, Suite 1010, Washington, D.C. 20005
(202) 962-4000 | 1-888-985-9246
  • Accessibility Policy
  • Disclaimer
  • Privacy Notice
  • Contact Us

Copyright ©
Society for Neuroscience